Hematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationTransplantation, HomologousTransplantation ConditioningStem Cell TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsHematologic NeoplasmsGraft vs Host DiseaseTreatment OutcomeMultiple MyelomaStem CellsMelphalanCombined Modality TherapyBone MarrowWhole-Body IrradiationRetrospective StudiesDisease-Free SurvivalBone Marrow CellsLymphoma, Non-HodgkinGraft SurvivalTransplantation ChimeraMyeloablative AgonistsTissue DonorsLiver TransplantationSurvival RateCyclophosphamideRecurrenceRemission InductionBusulfanHistocompatibility TestingImmunosuppressive AgentsLeukemiaAntigens, CD34Hematopoietic Stem Cell MobilizationHistocompatibilityCord Blood Stem Cell TransplantationSalvage TherapyHematopoiesisSurvival AnalysisKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsMesenchymal Stem Cell TransplantationAnemia, AplasticGraft vs Leukemia EffectCell TransplantationLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseTime FactorsCell DifferentiationTransplantation, IsogeneicTransplantation ImmunologyChimerismHLA AntigensHematologic DiseasesMice, Inbred C57BLMyelodysplastic SyndromesAdult Stem CellsGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Tumor EffectPrognosisLymphocyte TransfusionEmbryonic Stem CellsHeart TransplantationBone Marrow PurgingSevere Combined ImmunodeficiencyLymphocyte DepletionCell LineageFlow CytometryVidarabineStem Cell NicheImmunosuppressionBone and BonesAcute DiseaseGranulocyte Colony-Stimulating FactorT-LymphocytesSiblingsLung TransplantationFollow-Up StudiesColony-Forming Units AssayCytomegalovirus InfectionsOrgan TransplantationAntineoplastic AgentsCells, CulturedLeukemia, MyeloidAntilymphocyte SerumUnrelated DonorsMesenchymal Stromal CellsCytarabinePluripotent Stem CellsBone Marrow DiseasesCell SeparationTransplantationRadiation ChimeraCyclosporineFetal BloodHodgkin Disease